Determination of Product Thickness Applied on Different Areas of the Face Using a Multispectral Imaging Method
NCT ID: NCT05837208
Last Updated: 2023-05-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
26 participants
OBSERVATIONAL
2022-04-04
2022-04-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* the thickness of the RV4369A truly applied on different areas of the face after single application of the product determined by a multispectral imaging method.
* the influence of a second application of the product 15 to 30 minutes after the first application on the product thickness determined by multispectral imaging method.
* the influence of the recommendations of use provided to the subjects before application of the product on the product thickness determined by multispectral imaging method .
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Twelve Week Clinical Study to Evaluate the Efficacy and Tolerability of a Sunscreen Moisturizer SPF 50+
NCT06148558
UVA Protection Factors of SPF 50 and 50+ Face Sunscreens
NCT06068010
A Study of Two Facial Sunscreens to Assess Its Effect in Improving Hydration, Skin Barrier Function, and Skin Tone Uniformity Under Controlled and Normal Conditions of Use on the Face by Adult Participants
NCT05972434
Natural Sunlight Protection and Simulated Sunlight Protection Offered by Sunscreens and Fabrics
NCT03007589
A Study to Assess Effect of Two Facial Sunscreens in Improving Wrinkles, Fine Lines and Melasma in Adult Participants
NCT05864417
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Planning of the visits:
Visit 1: Inclusion visit (D1) Visit 2: End of study visit (D10), a window of +/- 2 days is allowed for this evaluation, \* The theoretical study duration for each subject is 10 days. The maximal study duration for each subject is 12 days.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Treated Group
all subjects will apply the study product RV4369A
RV4369A cosmetic product
The product is applied 1 or 2 times during the 2 study visits. The product is recovered by the technician after application of the product by the volunteer.
Application modalities:
Inclusion Assessment: The study product is given to the volunteer who applies it to his face (forehead) according to his usual habits.
After a waiting time and Multispectral camera measurements, the study product is again applied by the volunteer to his face according to his usual habits.
Final assessment: The study product is applied by the Clinical Research Technician on the subject's forearm on 4 delimited areas at specific quantities.
After a waiting period and Multispectral camera measurements on the forearm areas, the study product is given to the volunteer who applies it on his face according to the recommendations of use provided by the Technician.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
RV4369A cosmetic product
The product is applied 1 or 2 times during the 2 study visits. The product is recovered by the technician after application of the product by the volunteer.
Application modalities:
Inclusion Assessment: The study product is given to the volunteer who applies it to his face (forehead) according to his usual habits.
After a waiting time and Multispectral camera measurements, the study product is again applied by the volunteer to his face according to his usual habits.
Final assessment: The study product is applied by the Clinical Research Technician on the subject's forearm on 4 delimited areas at specific quantities.
After a waiting period and Multispectral camera measurements on the forearm areas, the study product is given to the volunteer who applies it on his face according to the recommendations of use provided by the Technician.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Phototype I to V inclusive.
* Absence of significant facial hair.
Exclusion Criteria
* Pregnant, breastfeeding women.
* For men: moustached or bearded.
* Substantial hair on the forearm and face.
* Application of keratolytic or self-tanning products to the face, forearms and arms in the four weeks prior to inclusion.
* With scars or other cutaneous characteristics, sunburn on forearms in the test areas, the size of which is considered incompatible with the study.
* Application of water, cleansing or beauty products to the forearms and arms since the last wash on the evening before inclusion.
Diseases :
* Known history of allergy to any of the investigational product ingredients.
* Known history of allergy to latex.
* Skin lesions or skin disease on the face or on the arms and forearms that may affect test results (seborrheic dermatitis, atopic dermatitis, psoriasis, acne, rosacea, etc.).
Treatments:
* Ongoing local or Oral treatment (retinoids, anti-inflammatory) that may affect test results.
20 Years
55 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pierre Fabre Dermo Cosmetique
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Thérèse Nocera, MD
Role: PRINCIPAL_INVESTIGATOR
Pierre Fabre Dermo Cosmetique
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Skin Research Center
Toulouse, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ADPROTECTPF
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.